Cargando…

Influence of peer networks on physician adoption of new drugs

Although physicians learn about new medical technologies from their peers, the magnitude and source of peer influence is unknown. We estimate the effect of peer adoption of three first-in-class medications (dabigatran, sitigliptin, and aliskiren) on physicians’ own adoption of those medications. We...

Descripción completa

Detalles Bibliográficos
Autores principales:	Donohue, Julie M., Guclu, Hasan, Gellad, Walid F., Chang, Chung-Chou H., Huskamp, Haiden A., Choudhry, Niteesh K., Zhang, Ruoxin, Lo-Ciganic, Wei-Hsuan, Junker, Stefanie P., Anderson, Timothy, Richards-Shubik, Seth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6166964/ https://www.ncbi.nlm.nih.gov/pubmed/30273368 http://dx.doi.org/10.1371/journal.pone.0204826

Ejemplares similares

Association between physician adoption of a new oral anti-diabetic medication and Medicare and Medicaid drug spending
por: Metes, Ilinca D., et al.
Publicado: (2019)

Adoption of telemedicine services by substance abuse treatment facilities in the U.S.
por: Uscher-Pines, Lori, et al.
Publicado: (2020)

Prescription Opioid Quality Measures Applied Among Pennsylvania Medicaid Enrollees
por: Cochran, Gerald, et al.
Publicado: (2018)

New chronic disease medication prescribing by nurse practitioners, physician assistants, and primary care physicians: a cohort study
por: Marcum, Zachary A., et al.
Publicado: (2016)

Association of Physician Peer Influence With Subsequent Physician Adoption and Use of Bevacizumab
por: Keating, Nancy L., et al.
Publicado: (2020)

Future Directions for the National Health Accounts
por: Huskamp, Haiden A., et al.
Publicado: (1999)

Paying Physicians to Prescribe Generic Drugs and Follow-On Biologics in the United States
por: Sarpatwari, Ameet, et al.
Publicado: (2015)

Integrating human services and criminal justice data with claims data to predict risk of opioid overdose among Medicaid beneficiaries: A machine-learning approach
por: Lo-Ciganic, Wei-Hsuan, et al.
Publicado: (2021)

Using machine learning to predict risk of incident opioid use disorder among fee-for-service Medicare beneficiaries: A prognostic study
por: Lo-Ciganic, Wei-Hsuan, et al.
Publicado: (2020)

Overturning the ACA’s Medicaid Expansion Would Likely Decrease Low-Income, Reproductive-Age Women’s Healthcare Spending and Utilization
por: Chen, Lucy, et al.
Publicado: (2020)

Evaluation of Machine-Learning Algorithms for Predicting Opioid Overdose Risk Among Medicare Beneficiaries With Opioid Prescriptions
por: Lo-Ciganic, Wei-Hsuan, et al.
Publicado: (2019)

Future Directions for the National Health Expenditure Accounts: Conference Overview
por: Huskamp, Haiden A., et al.
Publicado: (2006)

Rural access to MAT in Pennsylvania (RAMP): a hybrid implementation study protocol for medication assisted treatment adoption among rural primary care providers
por: Cochran, Gerald, et al.
Publicado: (2019)

Provision of evaluation and management visits by nurse practitioners and physician assistants in the USA from 2013 to 2019: cross-sectional time series study
por: Patel, Sadiq Y, et al.
Publicado: (2023)

Disruptions in Care for Medicare Beneficiaries With Severe Mental Illness During the COVID-19 Pandemic
por: Busch, Alisa B., et al.
Publicado: (2022)

Developing and validating a machine-learning algorithm to predict opioid overdose in Medicaid beneficiaries in two US states: a prognostic modelling study
por: Lo-Ciganic, Wei-Hsuan, et al.
Publicado: (2022)

Telemedicine Use and Quality of Opioid Use Disorder Treatment in the US During the COVID-19 Pandemic
por: Hailu, Ruth, et al.
Publicado: (2023)

Treatment of opioid use disorder during COVID-19: Experiences of clinicians transitioning to telemedicine()
por: Uscher-Pines, Lori, et al.
Publicado: (2020)

Assessment of Second-Generation Diabetes Medication Initiation Among Medicare Enrollees From 2007 to 2015
por: Gilstrap, Lauren G., et al.
Publicado: (2020)

Use of Telemedicine for Buprenorphine Inductions in Patients With Commercial Insurance or Medicare Advantage
por: Barsky, Benjamin A., et al.
Publicado: (2022)

Receipt of Out-of-State Telemedicine Visits Among Medicare Beneficiaries During the COVID-19 Pandemic
por: Mehrotra, Ateev, et al.
Publicado: (2022)

Community Factors Associated With Telemedicine Use During the COVID-19 Pandemic
por: Patel, Sadiq Y., et al.
Publicado: (2021)

A cohort study examining changes in treatment patterns for alcohol use disorder among commercially insured adults in the United States during the COVID-19 pandemic
por: Busch, Alisa B., et al.
Publicado: (2023)

Use of Data-Driven Methods to Predict Long-term Patterns of Health Care Spending for Medicare Patients
por: Lauffenburger, Julie C., et al.
Publicado: (2020)

Not there yet: using data-driven methods to predict who becomes costly among low-cost patients with type 2 diabetes
por: Lauffenburger, Julie C., et al.
Publicado: (2020)

Do internationally adopted children in the Netherlands use more medication than their non-adopted peers?
por: van Ginkel, Joost R., et al.
Publicado: (2016)

Changes in Drug Utilization during a Gap in Insurance Coverage: An Examination of the Medicare Part D Coverage Gap
por: Polinski, Jennifer M., et al.
Publicado: (2011)

Patient and Clinician Characteristics Associated with Use of Telemedicine for Buprenorphine Induction Among Medicare Beneficiaries
por: Patel, Sadiq Y., et al.
Publicado: (2022)

Comparison of Anticancer Medication Use and Spending Under US Oncology Parity Laws With and Without Out-of-Pocket Spending Caps
por: Dusetzina, Stacie B., et al.
Publicado: (2021)

Trends in Outpatient Telemedicine Utilization Among Rural Medicare Beneficiaries, 2010 to 2019
por: Barnett, Michael L., et al.
Publicado: (2021)

Association Between Telemedicine Use in Nonmetropolitan Counties and Quality of Care Received by Medicare Beneficiaries With Serious Mental Illness
por: Wang, Bill, et al.
Publicado: (2022)

Long-Term Prospects for Telemedicine in Opioid Use Disorder (OUD) Treatment: Results from a Longitudinal Survey of OUD Clinicians
por: Huskamp, Haiden A., et al.
Publicado: (2023)

Initiating Opioid Use Disorder Medication via Telemedicine During COVID-19: Implications for Proposed Reforms to the Ryan Haight Act
por: Huskamp, Haiden A., et al.
Publicado: (2021)

Primary care physicians’ approaches to low-value prescribing in older adults: a qualitative study
por: Pickering, Aimee N., et al.
Publicado: (2022)

Author Correction: The Impact of Text Messaging on Medication Adherence and Exercise Among Postmyocardial Infarction Patients: Randomized Controlled Pilot Trial
por: Pandey, Avinash, et al.
Publicado: (2019)

The Impact of Text Messaging on Medication Adherence and Exercise Among Postmyocardial Infarction Patients: Randomized Controlled Pilot Trial
por: Pandey, Avinash, et al.
Publicado: (2017)

Physician attitudes towards—and adoption of—mobile health
por: Kong, Tracie, et al.
Publicado: (2020)

Differences Between Managed Care and Fee-for-Service Medicaid in the Use of Generics for High-Rebate Drugs: The Cases of Insulin Glargine and Glatiramer
por: Hernandez, Inmaculada, et al.
Publicado: (2020)

Medication use and contextual factors associated with meeting guideline-based glycemic levels in diabetes among a nationally representative sample
por: McDaniel, Cassidi C., et al.
Publicado: (2023)

Physician Perceptions on Colonoscopy Quality: Results of a National Survey of Gastroenterologists
por: Gellad, Ziad F., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_4oert0j5qn4901bm7s95j5v5ar